Polysialic acid-targeting peptides: the future of human health treatment?
Researchers have designed peptide ligands with the ability to selectively bind to polysialic acid, which may prove useful in the treatment of a variety of diseases, such as Alzheimer’s, Parkinson’s and cancer. Researchers at Rensselaer Polytechnic Institute and Syracuse University (both NY, USA) have successfully designed chemically engineered peptide lipids that can selectively and specifically bind to polysialic acid, a carbohydrate that plays an important role in a variety of physiological and pathological processes. In the study, published recently in Scientific Reports, the researchers suggested that the peptides could have important implications for biological processes and biotechnological applications. The researchers...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!